🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A clinical study to determine the safety, efficacy and the way sitagliptin ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-14
Trial ID
NCT00704132
Treatments Being Tested
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
To compare the effect on glycemic control (HbA1c) of exenatide suspension a...
Status
Completed
Location
Research Site
Start Date
2013-02
Trial ID
NCT01652729
Treatments Being Tested
This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2008-01
Trial ID
NCT00971659
This trial is conducted in Japan. The purpose is to compare the safety of o...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2014-10-02
Trial ID
NCT02254291
Treatments Being Tested
The study is a multicenter, prospective, open-label, randomized pilot study...
Status
Completed
Location
Grady Memorial Hospital
Start Date
2011-08
Trial ID
NCT01378117
Treatments Being Tested
The purpose of this study is to determine the effects of sitagliptin on glu...
Status
Completed
Location
Barbara Davis Center for Childhood Diabetes
Start Date
2009-09
Trial ID
NCT00978796
Treatments Being Tested
This study was the extension of the LANTU\_C\_02761 study named EASIE and i...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00851903
Treatments Being Tested
Canadian physicians to experience in real life clinical practice the effica...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-01
Trial ID
NCT00833027
Treatments Being Tested
This is a Phase I, first-in-human, randomised, double-blinded, placebo-and ...
Status
Unknown
Location
Parexel International GmbH Early Phase Clinical Unit Klinikum Westend
Start Date
2021-07-07
Trial ID
NCT04982705